Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Real-Time PCR, Digital PCR And End-Point PCR Market Grown from 2024 to 2025?
The market size of real-time pcr, digital pcr, and end-point pcr has seen significant growth in the past few years. The market is predicted to expand from a value of $38.37 billion in 2024 to $41.88 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 9.2%. The considerable growth seen in the historical period can be attributed to the role of PCR protocols standardization, its involvement in tailored medical treatments, its significant contributions to drug discovery and development, as well as its increasing use in forensic and paternity testing.
What Growth Rate Is Anticipated for the Real-Time PCR, Digital PCR And End-Point PCR Market in the Coming Years?
The size of the market for real-time pcr, digital pcr and end-point pcr is forecasted to experience robust expansion in the forthcoming years. The market is projected to reach $60.91 billion by 2029, reflecting a compound annual growth rate (CAGR) of 9.8%. Factors contributing to growth during the forecast period include the enlargement of molecular diagnostics, increase in infectious disease screening, a surge in demand for genetic testing, market infiltration in research and forensics, as well as quick point-of-care PCR solutions. Anticipated trends for the forecast period are the rise of digital assays, advancements in multiplex PCR, a pivot towards digital PCR technology, the incorporation of automated and high-throughput systems, and the downsizing of PCR platforms.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13296&type=smp
Who Are the Leading Companies in the Real-Time PCR, Digital PCR And End-Point PCR Market?
Major companies operating in the real-time PCR, digital PCR and end-point PCR market report are F. Hoffmann La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Co., GE HealthCare Technologies Inc., Agilent Technologies Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Cole-Parmer Instrument Company LLC, Bioneer Corporation, Enzo Life Sciences Inc., Analytik Jena AG, Fluidigm Corporation, Elitech Group SAS, Microsynth AG, Stilla Technologies SAS, HTG Molecular Diagnostics Inc., AITbiotech Pte Ltd., Bio Molecular Systems, JN Medsys Pte Ltd., Biomeme Inc.
What Are the Key Drivers of the Real-Time PCR, Digital PCR And End-Point PCR Market?
Driven by an escalation in the prevalence of infectious diseases, the markets for real-time PCR, digital PCR, and end-point PCR are expected to experience accelerated growth. Infectious diseases are typically caused by the rapid growth and invasion of harmful bacteria, viruses, fungi, and parasites. Real-time, digital, and end-point PCR are critical tools in diagnosing these diseases, monitoring their progression as well as identifying specific pathogens or their genetic material. For instance, HIV, hepatitis, respiratory viruses, and tuberculosis are some of the diseases diagnosed swiftly using these technologies. In July 2023, UNAIDS reported that the global population with HIV rose to 39 million in 2022, an increase of 3.17% from 37.7 million in 2020. Additionally, in 2022 around 1.3 million new HIV cases were reported. In the United States, the Centers for Disease Control and Prevention highlighted an increase in tuberculosis cases from 7,874 in 2021 to 8,300 in 2022. Hence, the rise in infectious diseases is projected to propel the cephalosporin market’s growth. Real-time PCR, digital PCR, and end-point PCR markets are projected to be stimulated by the rising prevalence of chronic diseases. These long-term conditions gradually deteriorate overtime. Diagnosis of these diseases is possible due to real-time PCR that allows detection of specific DNA or RNA markers linked to these chronic conditions, such as cancer, diabetes, and viral infections. As per World Health Organization reports, in 2022, there were 41 million deaths due to non-communicable or chronic diseases, which comprises 74% of global deaths every year. There were 17.9 million deaths related to cardiovascular diseases, 9.3 million due to cancer, 4.1 million from chronic respiratory diseases, and 2.0 million resulting from diabetes. Therefore, the escalation in chronic diseases is acting as a catalyst for the growth of the real-time PCR, digital PCR, and end-point PCR market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=13296&type=smp
What Are the Key Market Segments in the Real-Time PCR, Digital PCR And End-Point PCR Industry?
The real-time pcr, digital pcr and end-point pcr market covered in this report is segmented –
1) By Product: Instruments, Consumables And Reagents, Software And Services
2) By Technology: Quantitative, End-Point Polymerase Chain Reaction (PCR), Digital
3) By Applications: Clinical, Research, Forensic, Other Applications
4) By End User: Hospital, Diagnostic Labs, Pharma, Biotech, Contract Research Organizations
Subsegments:
1) By Instruments: Real-Time PCR Systems, Digital PCR Systems, End-Point PCR Systems
2) By Consumables And Reagents: PCR Plates And Tubes, Primers And Probes, PCR Master Mix, DNA Polymerases And Nucleotides
3) By Software And Services: Analysis Software, Data Management Software, Calibration And Maintenance Services, Training And Support Services
What Are the Latest Trends in the Real-Time PCR, Digital PCR And End-Point PCR Market?
Leading firms in the real-time PCR, digital PCR, and end-point PCR markets are introducing innovative solutions using cutting-edge technologies like digital polymerase chain reaction (dPCR) technology. This technology helps to comprehensively analyze a patient’s cancer, genetic malady, or infection. dPCR technology is an enhanced version of traditional polymerase chain reaction (PCR) methods, having the capability to directly quantify and progressively reproduce nucleic acid strands such as DNA, cDNA, or RNA. For instance, Roche Diagnostics, an American medicines and medical equipment manufacturer, in August 2022 launched the next-gen digital PCR Digital LightCycler System. This system is designed for the early identification and treatment of a variety of chronic and genetic conditions. It takes care of automating workflow and managing data, thereby avoiding the necessity for external calculations, software, and processors. The system combines three nano well plate configurations, six sophisticated optical channels, and 5x concentrated DNA and RNA master mixes to offer high sensitivity and accuracy. Roche’s diagnostic platforms portfolio greatly benefits from the addition of the Digital LightCycler System, which offers state-of-the-art technology, clinical applications, customization and adaptability, and workflow automation.
Access The Full Report Here:
What Are the Key Regional Markets in the Real-Time PCR, Digital PCR And End-Point PCR Industry?
North America was the largest region in the real-time PCR, digital PCR, and end-point PCR market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time PCR, digital PCR and end-point PCR market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13296
This Report Delivers Insight On:
1. How big is the real-time pcr, digital pcr and end-point pcr market, and how is it changing globally?
2. Who are the major companies in the real-time pcr, digital pcr and end-point pcr market, and how are they performing?
3. What are the key opportunities and risks in the real-time pcr, digital pcr and end-point pcr market right now?
4. Which products or customer segments are growing the most in the real-time pcr, digital pcr and end-point pcr market?
5. What factors are helping or slowing down the growth of the real-time pcr, digital pcr and end-point pcr market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model